Intravenous Lidocaine Infusion in the Management of Post-operative Pain in Colorectal Patients
Withdrawn before enrolling · Phase 1/Phase 2
Conditions studied: Colorectal Disorders
In brief
The purpose of this study is to determine if an intravenous lidocaine infusion (compared to placebo) intraoperatively will decrease time to return of bowel function postoperatively, decrease postoperative pain, diminish postoperative opioid requirement, minimize inflammatory markers and shorten time to discharge after colorectal surgery.
Key facts
- Study ID
- NCT01836614
- Run by
- Children's Hospital Medical Center, Cincinnati
- People needed
- 0
- Starts
- 2015-01-01
- Expected to finish
- 2018-04-01
- Last updated by the study team
- 2016-03-08
Who can join
Age: 1 and older, up to 15. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- male or female children 1-15 years of age
- ASA physical status 1-3
- scheduled for colorectal surgery with abdominal incision
- scheduled for complex urology surgical case
You may not qualify if…
- ASA physical status > 3
- postoperative intubation planned ahead of surgery
- history of chronic use of opioid
- history of hepatic,renal, or cardiac failure
- history of organ transplant
- BMI > 30
- history of cardiac arrhythmia
- history of long QT syndrome
- history of allergic reaction to lidocaine or similar agents
- history of seizure disorder
- patient without Peripherally Inserted Central Catheter or other central access with contraindication to inhalation induction
- family history or know patient susceptibility to malignant hyperthermia
Where it is running
- Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.